As PD-L1 from cancer cells may bind PD-1 on T cells, enabling cancer cells to avoid T cell-mediated immune recognition, PD-L1, PD-L2, and PD-1 are significant ICI molecules. This evidence concerns the gene PDCD1LG2 and cancer.